"Designing Growth Strategies is in our DNA"

Chronic Lower Back Pain Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Non-steroidal Anti-Inflammatory Drugs, Antidepressants, Analgesic, Opioids, and Others), By Route of Administration (Oral, Topical, and Others), By Distribution Channel (Hospital Pharmacies and Retail & Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: January 26, 2026 | Format: PDF | Report ID: FBI100575

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Chronic Lower Back Pain, By Key Countries, 2026
    2. Pipeline Analysis, Key Players
    3. Key Industry Developments, Key Players
    4. Impact of COVID-19 on the Market
  5. Global Chronic Lower Back Pain Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-Inflammatory Drugs
      2. Antidepressants
      3. Analgesic
      4. Opioids
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Chronic Lower Back Pain Treatment Market Analysis, Insights and Forecast, 2021-2029
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-Inflammatory Drugs
      2. Antidepressants
      3. Analgesic
      4. Opioids
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe Chronic Lower Back Pain Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-Inflammatory Drugs
      2. Antidepressants
      3. Analgesic
      4. Opioids
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Chronic Lower Back Pain Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-Inflammatory Drugs
      2. Antidepressants
      3. Analgesic
      4. Opioids
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. China
      2. India
      3. Japan
      4. Australia
      5. South East Asia
      6. Rest of Asia Pacific
  9. Latin America Chronic Lower Back Pain Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-Inflammatory Drugs
      2. Antidepressants
      3. Analgesic
      4. Opioids
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Chronic Lower Back Pain Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-Inflammatory Drugs
      2. Antidepressants
      3. Analgesic
      4. Opioids
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2026)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Pfizer Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Lilly
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. GSK plc
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Johnson & Johnson Services, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Merck & Co, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Sanofi
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Dr. Reddy's Laboratories
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Bayer AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Endo International plc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Chronic Lower Back Pain, By Key Countries, 2026
    2. Pipeline Analysis, Key Players
    3. Key Industry Developments, Key Players
    4. Impact of COVID-19 on the Market
  5. Global Chronic Lower Back Pain Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-Inflammatory Drugs
      2. Antidepressants
      3. Analgesic
      4. Opioids
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Chronic Lower Back Pain Treatment Market Analysis, Insights and Forecast, 2021-2029
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-Inflammatory Drugs
      2. Antidepressants
      3. Analgesic
      4. Opioids
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe Chronic Lower Back Pain Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-Inflammatory Drugs
      2. Antidepressants
      3. Analgesic
      4. Opioids
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Chronic Lower Back Pain Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-Inflammatory Drugs
      2. Antidepressants
      3. Analgesic
      4. Opioids
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. China
      2. India
      3. Japan
      4. Australia
      5. South East Asia
      6. Rest of Asia Pacific
  9. Latin America Chronic Lower Back Pain Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-Inflammatory Drugs
      2. Antidepressants
      3. Analgesic
      4. Opioids
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Chronic Lower Back Pain Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Non-steroidal Anti-Inflammatory Drugs
      2. Antidepressants
      3. Analgesic
      4. Opioids
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Topical
      3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2026)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Pfizer Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Lilly
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. GSK plc
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Johnson & Johnson Services, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Merck & Co, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Sanofi
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Dr. Reddy's Laboratories
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Bayer AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Endo International plc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Chronic Lower Back Pain Treatment Market Revenue Breakdown (USD billion, %) by Region, 2026 & 2034

Figure 2:  Global Chronic Lower Back Pain Treatment Market Value Share (%), By Drug Class, 2026 & 2034

Figure 3: Global Chronic Lower Back Pain Treatment Market Value Share (%), By Route of Administration, 2026 & 2034

Figure 4: Global Chronic Lower Back Pain Treatment Market Value Share (%), By Distribution Channel, 2026 & 2034

Figure 5: Global Chronic Lower Back Pain Treatment Market Value (USD billion), By Region, 2026 & 2034

Figure 6: North America Chronic Lower Back Pain Treatment Market Value (USD billion), by Drug Class, 2026 & 2034

Figure 7:  North America Chronic Lower Back Pain Treatment Market Value Share (%), by Drug Class, 2026

Figure 8: North America Chronic Lower Back Pain Treatment Market Value (USD billion), by Route of Administration, 2026 & 2034

Figure 9: North America Chronic Lower Back Pain Treatment Market Value Share (%), by Route of Administration, 2026

Figure 10: North America Chronic Lower Back Pain Treatment Market Value (USD billion), by Distribution Channel, 2026 & 2034

Figure 11: North America Chronic Lower Back Pain Treatment Market Value Share (%), by Distribution Channel, 2026

Figure 12:  North America Chronic Lower Back Pain Treatment Market Value (USD billion), by Country, 2026 & 2034

Figure 13:  North America Chronic Lower Back Pain Treatment Market Value Share (%), by Country, 2026

Figure 14:  Europe Chronic Lower Back Pain Treatment Market Value (USD billion), by Drug Class, 2026 & 2034

Figure 15:  Europe Chronic Lower Back Pain Treatment Market Value Share (%), by Drug Class, 2026

Figure 16:  Europe Chronic Lower Back Pain Treatment Market Value (USD billion), by Route of Administration, 2026 & 2034

Figure 17:  Europe Chronic Lower Back Pain Treatment Market Value Share (%), by Route of Administration, 2026

Figure 18: Europe Chronic Lower Back Pain Treatment Market Value (USD billion), by Distribution Channel, 2026 & 2034

Figure 19: Europe Chronic Lower Back Pain Treatment Market Value Share (%), by Distribution Channel, 2026

Figure 20: Europe Chronic Lower Back Pain Treatment Market Value (USD billion), by Country/ Sub-Region, 2026 & 2034

Figure 21:  Europe Chronic Lower Back Pain Treatment Market Value Share (%), by Country/ Sub-Region, 2026

Figure 22:  Asia Pacific Chronic Lower Back Pain Treatment Market Value (USD billion), by Drug Class, 2026 & 2034

Figure 23:  Asia Pacific Chronic Lower Back Pain Treatment Market Value Share (%), by Drug Class, 2026

Figure 24:  Asia Pacific Chronic Lower Back Pain Treatment Market Value (USD billion), by Route of Administration, 2026 & 2034

Figure 25:  Asia Pacific Chronic Lower Back Pain Treatment Market Value Share (%), by Route of Administration, 2026

Figure 26:  Asia Pacific Chronic Lower Back Pain Treatment Market Value (USD billion), by Distribution Channel, 2026 & 2034

Figure 27:  Asia Pacific Chronic Lower Back Pain Treatment Market Value Share (%), by Distribution Channel, 2026

Figure 28:  Asia Pacific Chronic Lower Back Pain Treatment Market Value (USD billion), by Country/ Sub-Region, 2026 & 2034

Figure 29:  Asia Pacific Chronic Lower Back Pain Treatment Market Value Share (%), by Country/ Sub-Region, 2026

Figure 30:  Latin America Chronic Lower Back Pain Treatment Market Value (USD billion), by Drug Class, 2026 & 2034

Figure 31:  Latin America Chronic Lower Back Pain Treatment Market Value Share (%), by Drug Class, 2026

Figure 32:  Latin America Chronic Lower Back Pain Treatment Market Value (USD billion), by Route of Administration, 2026 & 2034

Figure 33:  Latin America Chronic Lower Back Pain Treatment Market Value Share (%), by Route of Administration, 2026

Figure 34:  Latin America Chronic Lower Back Pain Treatment Market Value (USD billion), by Distribution Channel, 2026 & 2034

Figure 35:  Latin America Chronic Lower Back Pain Treatment Market Value Share (%), by Distribution Channel, 2026

Figure 36:  Latin America Chronic Lower Back Pain Treatment Market Value (USD billion), by Country/ Sub-Region, 2026 & 2034

Figure 37:  Latin America Chronic Lower Back Pain Treatment Market Value Share (%), by Country/ Sub-Region, 2026

Figure 38:  Middle East & Africa Chronic Lower Back Pain Treatment Market Value (USD billion), by Drug Class, 2026 & 2034

Figure 39:  Middle East & Africa Chronic Lower Back Pain Treatment Market Value Share (%), by Drug Class, 2026

Figure 40:  Middle East & Africa Chronic Lower Back Pain Treatment Market Value (USD billion), by Route of Administration, 2026 & 2034

Figure 41:  Middle East & Africa Chronic Lower Back Pain Treatment Market Value Share (%), by Route of Administration, 2026

Figure 42:  Middle East & Africa Chronic Lower Back Pain Treatment Market Value (USD billion), by Distribution Channel, 2026 & 2034

Figure 43:  Middle East & Africa Chronic Lower Back Pain Treatment Market Value Share (%), by Distribution Channel, 2026

Figure 44:  Middle East & Africa Chronic Lower Back Pain Treatment Market Value (USD billion), by Country/ Sub-Region, 2026 & 2034

Figure 45:  Middle East & Africa Chronic Lower Back Pain Treatment Market Value Share (%), by Country/ Sub-Region, 2026

Figure 46: Global Chronic Lower Back Pain Treatment Market Share Analysis, By Company, 2026

Table 1:  Global Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 2:  Global Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2021-2034

Table 3:  Global Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 4:  Global Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Region, 2021-2034

Table 5:  North America Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 6:  North America Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2021-2034

Table 7:  North America Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 8:  North America Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 9:  Europe Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 10:  Europe Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2021-2034

Table 11:  Europe Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 12:  Europe Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 13:  Asia Pacific Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 14:  Asia Pacific Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2021-2034

Table 15:  Asia Pacific Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 16:  Asia Pacific Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 17:  Latin America Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 18:  Latin America Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2021-2034

Table 19:  Latin America Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 20:  Latin America Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 21:  Middle East & Africa Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 22:  Middle East & Africa Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2021-2034

Table 23:  Middle East & Africa Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 24:  Middle East & Africa Chronic Lower Back Pain Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Chronic Lower Back Pain Treatment Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 150
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports